Latest Capital Raising News

PhosCo Ltd advances its Gasaat Phosphate Project with robust drilling results at KM and SAB deposits, confirming thick, high-grade mineralisation. Imminent maiden resource estimates and a significant new discovery at DOH underscore the project's growing global significance amid supply chain disruptions.

Horizon Gold has confirmed new high-grade gold shoots at its Kingfisher prospect, underpinning resource growth potential, while progressing a major $30 million capital raise and leadership transition.

Skylark Minerals has kicked off its largest drilling campaign at the Zaranou Gold Project in Côte d’Ivoire, confirming deeper and thicker gold mineralisation that could expand its 364,600-ounce inferred resource.

Entropy Neurodynamics has reported encouraging early clinical outcomes from its pioneering intravenous psilocin therapy for Binge Eating Disorder, alongside a patent grant that strengthens its intellectual property moat.

1414 Degrees (ASX:14D) advances its SiNTL silicon anode technology, aiming to disrupt lithium-ion batteries in the rapidly expanding drone and UAV sector with higher capacity and faster charging.

PYC Therapeutics fortified its balance sheet by $600 million and progressed key RNA therapeutic trials in Q1 2026, setting the stage for pivotal clinical data and regulatory submissions.

Pivotal Metals is progressing a mineral resource update and scoping study for its Horden Lake copper project in Québec, targeting a large open-pit operation with strong cashflow potential amid record copper prices.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Recharge Metals has kicked off exploration at its Sunset Well Gold Project in WA, backed by a $6 million war chest and a leadership reshuffle bringing in geologist Luke Timmermans as CEO.

Resolution Minerals has successfully produced high-grade tungsten concentrates from historical stockpiles at its Golden Gate mine, achieving a 19-fold upgrade and strong recovery rates using simple gravity separation techniques.

European Resources has more than doubled its Korsnäs rare earth resource following a successful drilling program and metallurgical advances, underpinning a $3.4 million capital raise to fund further development.

INOVIQ Limited is on track to complete its EXO-OC™ ovarian cancer screening study by mid-2026 and is accelerating its CAR-exosome therapy program, supported by a strong cash position of A$11.9 million.